Literature DB >> 12805447

Dynamics of viral and proviral loads of feline immunodeficiency virus within the feline central nervous system during the acute phase following intravenous infection.

G Ryan1, D Klein, E Knapp, M J Hosie, T Grimes, M J E M F Mabruk, O Jarrett, J J Callanan.   

Abstract

Animal models of human immunodeficiency virus 1, such as feline immunodeficiency virus (FIV), provide the opportunities to dissect the mechanisms of early interactions of the virus with the central nervous system (CNS). The aims of the present study were to evaluate viral loads within CNS, cerebrospinal fluid (CSF), ocular fluid, and the plasma of cats in the first 23 weeks after intravenous inoculation with FIV(GL8). Proviral loads were also determined within peripheral blood mononuclear cells (PBMCs) and brain tissue. In this acute phase of infection, virus entered the brain in the majority of animals. Virus distribution was initially in a random fashion, with more diffuse brain involvement as infection progressed. Virus in the CSF was predictive of brain parenchymal infection. While the peak of virus production in blood coincided with proliferation within brain, more sustained production appeared to continue in brain tissue. In contrast, proviral loads in the brain decreased to undetectable levels in the presence of a strengthening PBMC load. A final observation in this study was that there was no direct correlation between viral loads in regions of brain or ocular tissue and the presence of histopathology.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12805447      PMCID: PMC164807          DOI: 10.1128/jvi.77.13.7477-7485.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  66 in total

1.  High virus loads in naturally and experimentally SIVagm-infected African green monkeys.

Authors:  S Holzammer; E Holznagel; A Kaul; R Kurth; S Norley
Journal:  Virology       Date:  2001-05-10       Impact factor: 3.616

2.  Vaccination with inactivated virus but not viral DNA reduces virus load following challenge with a heterologous and virulent isolate of feline immunodeficiency virus.

Authors:  M J Hosie; T Dunsford; D Klein; B J Willett; C Cannon; R Osborne; J Macdonald; N Spibey; N Mackay; O Jarrett; J C Neil
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

3.  Virulence differences between two field isolates of feline immunodeficiency virus (FIV-APetaluma and FIV-CPGammar) in young adult specific pathogen free cats.

Authors:  N C Pedersen; C M Leutenegger; J Woo; J Higgins
Journal:  Vet Immunol Immunopathol       Date:  2001-05-10       Impact factor: 2.046

Review 4.  The feline model of neuroAIDS: understanding the progression towards AIDS dementia.

Authors:  M Podell; P A March; W R Buck; L E Mathes
Journal:  J Psychopharmacol       Date:  2000       Impact factor: 4.153

5.  Rapid feline immunodeficiency virus provirus quantitation by polymerase chain reaction using the TaqMan fluorogenic real-time detection system.

Authors:  C M Leutenegger; D Klein; R Hofmann-Lehmann; C Mislin; U Hummel; J Böni; F Boretti; W H Guenzburg; H Lutz
Journal:  J Virol Methods       Date:  1999-03       Impact factor: 2.014

6.  Reservoirs of human immunodeficiency virus type 1: the main obstacles to viral eradication.

Authors:  Roger J Pomerantz
Journal:  Clin Infect Dis       Date:  2001-11-21       Impact factor: 9.079

7.  Proviral load determination of different feline immunodeficiency virus isolates using real-time polymerase chain reaction: influence of mismatches on quantification.

Authors:  D Klein; P Janda; R Steinborn; M Müller; B Salmons; W H Günzburg
Journal:  Electrophoresis       Date:  1999-02       Impact factor: 3.535

8.  Viral load and neuropathology in the SIV model.

Authors:  D Boche; E Khatissian; F Gray; P Falanga; L Montagnier; B Hurtrel
Journal:  J Neurovirol       Date:  1999-06       Impact factor: 2.643

9.  Real-time TaqMan PCR as a specific and more sensitive alternative to the branched-chain DNA assay for quantitation of simian immunodeficiency virus RNA.

Authors:  C M Leutenegger; J Higgins; T B Matthews; A F Tarantal; P A Luciw; N C Pedersen; T W North
Journal:  AIDS Res Hum Retroviruses       Date:  2001-02-10       Impact factor: 2.205

10.  Neurological disorders during HIV-1 infection correlate with viral load in cerebrospinal fluid but not with virus phenotype.

Authors:  M Di Stefano; L Monno; J R Fiore; G Buccoliero; A Appice; L M Perulli; G Pastore; G Angarano
Journal:  AIDS       Date:  1998-05-07       Impact factor: 4.177

View more
  17 in total

1.  Suppression of immunodeficiency virus-associated neural damage by the p75 neurotrophin receptor ligand, LM11A-31, in an in vitro feline model.

Authors:  Rick B Meeker; Winona Poulton; Wen-hai Feng; Lola Hudson; Frank M Longo
Journal:  J Neuroimmune Pharmacol       Date:  2011-12-10       Impact factor: 4.147

2.  Transmigration of macrophages across the choroid plexus epithelium in response to the feline immunodeficiency virus.

Authors:  Rick B Meeker; D C Bragg; Winona Poulton; Lola Hudson
Journal:  Cell Tissue Res       Date:  2012-01-27       Impact factor: 5.249

3.  TaqMan real-time reverse transcription-PCR and JDVp26 antigen capture enzyme-linked immunosorbent assay to quantify Jembrana disease virus load during the acute phase of in vivo infection.

Authors:  Meredith Stewart; Moira Desport; Nining Hartaningsih; Graham Wilcox
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

4.  Cerebrospinal fluid is an efficient route for establishing brain infection with feline immunodeficiency virus and transfering infectious virus to the periphery.

Authors:  Pinghuang Liu; Lola C Hudson; Mary B Tompkins; Thomas W Vahlenkamp; Brenda Colby; Cyndi Rundle; Rick B Meeker
Journal:  J Neurovirol       Date:  2006-08       Impact factor: 2.643

5.  Compartmentalization and evolution of feline immunodeficiency virus between the central nervous system and periphery following intracerebroventricular or systemic inoculation.

Authors:  Pinghuang Liu; Lola C Hudson; Mary B Tompkins; Thomas W Vahlenkamp; Rick B Meeker
Journal:  J Neurovirol       Date:  2006-08       Impact factor: 2.643

6.  Neuropathology associated with feline immunodeficiency virus infection highlights prominent lymphocyte trafficking through both the blood-brain and blood-choroid plexus barriers.

Authors:  Gavin Ryan; Terence Grimes; Brenda Brankin; Mohamad J E M F Mabruk; Margaret J Hosie; Oswald Jarrett; John J Callanan
Journal:  J Neurovirol       Date:  2005-08       Impact factor: 2.643

7.  Endothelial cell suppression of peripheral blood mononuclear cell trafficking in vitro during acute exposure to feline immunodeficiency virus.

Authors:  Lola C Hudson; Mary B Tompkins; Rick B Meeker
Journal:  Cell Tissue Res       Date:  2008-07-30       Impact factor: 5.249

8.  Characterization of a highly pathogenic molecular clone of feline immunodeficiency virus clade C.

Authors:  Sohela de Rozières; Candace K Mathiason; Matthew R Rolston; Udayan Chatterji; Edward A Hoover; John H Elder
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

Review 9.  Neurologic disease in feline immunodeficiency virus infection: disease mechanisms and therapeutic interventions for NeuroAIDS.

Authors:  Christopher Power
Journal:  J Neurovirol       Date:  2017-12-15       Impact factor: 2.643

Review 10.  Feline immunodeficiency virus neuropathogenesis: from cats to calcium.

Authors:  Rick B Meeker
Journal:  J Neuroimmune Pharmacol       Date:  2006-11-28       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.